A/S Ferrosan

Patent Applications and Registrations

Patent applications and USPTO patent grants for A/S Ferrosan.The latest application filed is for ".beta.-carbolin-3-carboxylic acid derivatives useful for treating anxiety and related disorders".

Company Profile

0.21.0

A/S Ferrosan - Soeborg DK
A/S Ferrosan - Soborg DK
A/S Ferrosan - Sydmarken DE
A/S Ferrosan - Soberg DK
A/S Ferrosan - DK DK
A/S Ferrosan - Copenhagen DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
.beta.-carbolin-3-carboxylic acid derivatives useful for treating anxiety and related disorders Grant 5,010,077 - Braestrup , et al. April 23, 1	1991-04-23
Piperidine compounds and pharmaceutical compositions thereof Grant 4,985,446 - Drejer , et al. January 15, 1	1991-01-15
1,2,3-triazolo compounds Grant 4,977,155 - Jacobsen , et al. December 11, 1	1990-12-11
Cycloalkyl or benzyl-6-substituted-quinoxalinediones Grant 4,948,794 - Honore , et al. August 14, 1	1990-08-14
Lipophilically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions (II) Grant 4,933,353 - Jensen , et al. June 12, 1	1990-06-12
Pyridoquinoxaline compounds and their preparation and use as glutamate antagonists Grant 4,912,108 - Jacobsen , et al. March 27, 1	1990-03-27
Heterocyclic compounds and their preparation and use Grant 4,889,855 - Jacobsen , et al. December 26, 1	1989-12-26
Method of treating calcium overload in brain cells of mammals Grant 4,877,799 - Drejer , et al. October 31, 1	1989-10-31
Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions Grant 4,837,241 - Jensen , et al. June 6, 1	1989-06-06
6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics Grant 4,812,458 - Honore , et al. March 14, 1	1989-03-14
Imidazoquinoxaline compounds Grant 4,774,245 - Watjen , et al. September 27, 1	1988-09-27
Benzodiazepine derivatives and their preparation and use Grant 4,772,599 - Watjen September 20, 1	1988-09-20
3-substituted-4,5-dihydro-5-oxo imidazoquinazolines, their preparation, and their use in treating benzodiazepin receptor-related ailments Grant 4,771,051 - Watjen , et al. September 13, 1	1988-09-13
Method for treating obesity Grant 4,745,122 - Lassen May 17, 1	1988-05-17
(-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)meth yl]-1-methylpiperidine useful as 5-HT potentiator Grant 4,593,036 - Lassen , et al. June 3, 1	1986-06-03
Optical resolution of racemic femoxetine Grant 4,571,424 - Christensen , et al. February 18, 1	1986-02-18
Oxadiazolyl-imidazo-[1,4]benzodiazepines and their use in treatment of diseases of the central nervous system Grant 4,507,313 - Braestrup , et al. March 26, 1	1985-03-26
.beta.-Carbolin-3-carboxylic acid derivatives Grant 4,371,536 - Braestrup , et al. February 1, 1	1983-02-01
4-Phenylpiperidine compounds Grant 4,007,196 - Christensen , et al. * February 8, 1	1977-02-08
4-Phenylpiperidine compounds Grant 3,912,743 - Christensen , et al. October 14, 1	1975-10-14
Preparations containing fat-soluble vitamins in dry, particulate, free-flowing form dispersible in cold water and method of producing such preparations Grant 3,869,539 - Kring , et al. March 4, 1	1975-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.